Sierra Oncology to Present at B. Riley Securities Oncology Investor Conference

Rhea-AI Summary

Sierra Oncology (NASDAQ: SRRA), a late-stage biopharmaceutical firm focused on rare cancers, will participate in the B. Riley Securities Oncology Investor Conference on January 27-28, 2022. CEO Stephen Dilly will present an overview of the company on January 28 at 2:30 pm ET. A replay of this presentation will be available for 30 days on Sierra's website in the Events & Webcast section. Sierra is committed to transforming cancer treatments through targeted therapies, utilizing scientific expertise to advance innovative solutions for patients.

SAN MATEO, Calif.--(BUSINESS WIRE)-- Sierra Oncology, Inc. (NASDAQ: SRRA), a late-stage biopharmaceutical company dedicated to delivering targeted therapies for rare cancers, today announced the company will participate in the 2022 B. Riley Securities Oncology Investor Conference being held virtually from January 27-28, 2022. President and Chief Executive Officer Stephen Dilly, MBBS, PhD, will provide an overview of the company at 2:30 pm ET on Friday, January 28, 2022.

A replay of the presentation will be available following the conference on the Investors section of Sierra’s corporate website in the Events & Webcast tab. The replay will be available for approximately 30 days following the presentation.

About Sierra Oncology
Sierra Oncology is a late-stage biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer. We harness our deep scientific expertise to identify compounds that target the root cause of disease to advance targeted therapies with assets on the leading edge of cancer biology. Our team takes an evidence-based approach to understand the limitations of current treatments and explore new ways to change the cancer treatment paradigm. Together we are transforming promise into patient impact.

For more information, visit www.SierraOncology.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220127005358/en/

Investors

DeDe Sheel

415.732.9828

dsheel@sierraoncology.com

Media

Lauren Musto

615.351.7777

lmusto@sierraoncology.com

Source: Sierra Oncology

FAQ

When will Sierra Oncology present at the B. Riley Securities Oncology Investor Conference?

Sierra Oncology will present on January 28, 2022, at 2:30 pm ET.

How can I access the replay of Sierra Oncology's conference presentation?

The replay will be available for 30 days on Sierra Oncology's corporate website in the Events & Webcast tab.

What is the main focus of Sierra Oncology?

Sierra Oncology specializes in targeted therapies for rare cancers.

What is the ticker symbol for Sierra Oncology?

The ticker symbol for Sierra Oncology is SRRA.

Where is the B. Riley Securities Oncology Investor Conference being held?

The conference is being held virtually on January 27-28, 2022.